Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “or Severe Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT01621178
What this trial is testing

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

Who this might be right for
Type 2 DiabetesChronic Kidney Disease
Eli Lilly and Company 577
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT02512068
What this trial is testing

A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 107
Large-scale testing (Phase 3)Looking for participantsNCT07241390
What this trial is testing

Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Who this might be right for
Atherosclerosis Cardiovascular DiseaseChronic Kidney Disease
Eli Lilly and Company 7,140
Testing effectiveness (Phase 2)Looking for participantsNCT04580420
What this trial is testing

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Who this might be right for
Primary Hyperoxaluria Type 1End Stage Renal Disease
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 28
Large-scale testing (Phase 3)Ended earlyNCT04968184
What this trial is testing

Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Diseases
KBP Biosciences 652
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Testing effectiveness (Phase 2)Study completedNCT02045017
What this trial is testing

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

Who this might be right for
Multiple Myeloma
Celgene 81
Large-scale testing (Phase 3)Active Not RecruitingNCT06297603
What this trial is testing

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 320
Large-scale testing (Phase 3)Active Not RecruitingNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000
Testing effectiveness (Phase 2)WithdrawnNCT02397395
What this trial is testing

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Who this might be right for
Renal ImpairmentEnd-stage Renal Disease
Janssen R&D Ireland
Large-scale testing (Phase 3)Study completedNCT02207088
What this trial is testing

Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis+2 more
AbbVie 68